Skip to main content
SpringerLink
Log in

Clinical uses of nalidixic acid analogues: the fluoroquinolones

  • Editorials
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wolfson, J. S., Hooper, D. C.: The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 1985, 28: 581–586.

    PubMed  CAS  Google Scholar 

  2. Smith, J. T.: Awakening the slumbering potential of the 4-quinolone antibacterials. Pharmaceutical Journal 1984, 233: 299–305.

    CAS  Google Scholar 

  3. Benbrook, D. M., Miller, R. V.: Effects of norfloxacin on DNA metabolism inPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1986, 29: 1–6.

    PubMed  CAS  Google Scholar 

  4. Crumplin, G. C., Kenwright, M., Hirst, T.: Investigations into the mechanism of action of the antibacterial agent norfloxacin. Journal of Antimicrobial Chemotherapy 1984, 13, Supplement B: 9–23.

    CAS  PubMed  Google Scholar 

  5. Chalkley, L. J., Koornhof, H. J.: Antimicrobial activity of ciprofloxacin againstPseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrobial Agents and Chemotherapy 1985, 28: 331–342.

    PubMed  CAS  Google Scholar 

  6. Davies, G. S. R., Cohen, J.: In vitro study of the activity of ciprofloxacin alone and in combination against strains ofPseudomonas aeruginosa with multiple antibiotic resistance. Journal of Antimicrobial Chemotherapy 1985, 16: 713–717.

    PubMed  CAS  Google Scholar 

  7. Haller, I.: Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations againstEnterobacteriacae andPseudomonas aeruginosa strains. Antimicrobial Agents and Chemotherapy 1985, 28: 663–666.

    PubMed  CAS  Google Scholar 

  8. Van der Auwera, P.: Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoroquinolones againstEnterobacteriaceae andPseudomonas aeruginosa Journal of Antimicrobial Chemotherapy 1985, 16: 581–587.

    PubMed  Google Scholar 

  9. Barry, A. L., Jones, R. N.: Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations. Antimicrobial Agents and Chemotherapy 1984, 25: 775–777.

    PubMed  CAS  Google Scholar 

  10. Smith, J. T.: Mutational resistance to 4-quinolone antibacterial agents. European Journal of Clinical Microbiology 1984, 3: 347–350.

    Article  PubMed  CAS  Google Scholar 

  11. Weisser, J., Wiedemann, B.: Elimination of plasmids by new 4-quinolones. Antimicrobial Agents and Chemotherapy 1985, 28: 700–702.

    PubMed  CAS  Google Scholar 

  12. Hooper, D. C., Wolfson, J. S.: The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrobial Agents and Chemotherapy 1985, 28: 716–721.

    PubMed  CAS  Google Scholar 

  13. Young, L. S.: Clinical experience with the newer quinolones. Research and Clinical Forums 1985, 7: 97–114.

    Google Scholar 

  14. Blomer, R., Bruch, K., Heinen, B., Raff, P.: Ofloxacin. Clinical studies. Chemiotherapia 1985, 4, Supplement: 366–367.

    Google Scholar 

  15. Reeves, D. S., Lacey, R. W., Mummery, R. V., Mahendra, M., Bint, A. J., Newsom, S. W. B.: Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study. Journal of Antimicrobial Chemotherapy 1984, 13, Supplement B: 99–105.

    PubMed  Google Scholar 

  16. Sabbaj, J., Hoagland, V. L., Shih, W. J.: Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections. Antimicrobial Agents and Chemotherapy 1985 27: 297–301.

    PubMed  CAS  Google Scholar 

  17. Watt, B., Chait, I., Kelsey, M. C., Newsom, S. W. B., Newsom, R. A., Smith, J., Toase, P. D., Deaney, N. B., Round, E. M., Vogel, R., Currie, W. J. C.: Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections — a multicentre trial. Journal of Antimicrobial Chemotherapy 1984, 13, Supplement: 89–94.

    PubMed  Google Scholar 

  18. Leigh, D. A., Smith, E. C., Marriner, J.: Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients. Journal of Antimicrobial Chemotherapy 1984, 13, Supplement B: 79–83.

    PubMed  Google Scholar 

  19. Haase, D. A., Harding, G. K. M., Thomson, M. J., Kennedy, J. K., Urias, B. A., Ronald, A. R.: Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. Antimicrobial Agents and Chemotherapy 1984, 26: 481–484.

    PubMed  CAS  Google Scholar 

  20. Guerra, J. G., Falconi, E., Palomino, J. C., Benavente, L.: Norfloxacin versus co-trimoxazole in infections of the kidney. European Journal of Chemotherapy and Antibiotics 1983, 3: 47–52.

    Google Scholar 

  21. Goldstein, E. J. C., Alpert, M. L., Ginsberg, B. P.: Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrobial Agents and Chemotherapy 1985, 27: 422–423.

    PubMed  CAS  Google Scholar 

  22. Giamarellou, H., Tsagarakis, J., Seitanides, B., Daikos, G. K.: Norfloxacin in the treatment of recurrent urinary tract infections. European Journal of Chemotherapy and Antibiotics 1983, 3: 27–30.

    Google Scholar 

  23. Ball, A. P., Fox, C., Brown, I. R. F.: Clinical efficacy and kinetics of ciprofloxacin in UTI. Chemiotherapia 1985, 4, Supplement: 406–407.

    Google Scholar 

  24. Naber, K. G., Bartosik-Which, B.: Therapy of complicated urinary tract infections with norfloxacin versus ciprofloxacin and pharmacokinetics in elderly patients. Chemiotherapia 1985, 4, Supplement: 411–413.

    Google Scholar 

  25. Kosmidis, J., Macrygiannis, E., Aboudabash, B.: A prospective, randomized comparison of ciprofloxacin and cotrimoxazole in urinary tract infections: in vitro, pharmacokinetics and therapeutic evaluation. Chemiotherapia 1985, 4, Supplement: 413–414.

    Google Scholar 

  26. Crider, S. R., Colby, S. D., Miller, L. K., Harrison, W. O., Kerbs, S. B. J., Berg, S. W.: Treatment of penicillin-resistantNeisseria gonorrhoeae with oral norfloxacin. New England Journal of Medicine 1984, 311: 137–140.

    Article  PubMed  CAS  Google Scholar 

  27. Leigh, D. A., Emmanuel, F. X. S.: The treatment ofPseudomonas aeruginosa urinary tract infections with norfloxacin. Journal of Antimicrobial Chemotherapy 1984, 13, Supplement B: 85–88.

    PubMed  Google Scholar 

  28. Eron, L. J., Harvey, L., Hixon, D. L., Poretz, D. M.: Ciprofloxacin therapy of infections caused byPseudomonas aeruginosa and other resistant bacteria. Antimicrobial Agents and Chemotherapy 1985, 27: 308–310.

    Google Scholar 

  29. Giamarellou, H., Daphnis, E., Dendrinos, C., Daikos, G. K.: Experience with ciprofloxacin in the treatment of various infections caused mainly byPseudomonas aeruginosa. Drugs under Experimental and Clinical Research 1985, 11: 351–356.

    PubMed  CAS  Google Scholar 

  30. Bailey, R. R., Peddie, B. A.: Enoxacin for the treatment of urinary tract infection. New Zealand Medical Journal 1985, 98: 286–288.

    PubMed  CAS  Google Scholar 

  31. Notowicz, A., Stolz, E., van Klingeren, B.: A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement C: 91–94.

    PubMed  Google Scholar 

  32. Steru, D., Cheron, G., Perignon, F., Fauchere, J. C., Lenoir, G.: Is the new oral quinolone, pefloxacin, useful for the management of chronicPseudomonas aeruginosa infections in children with cystic fibrosis? In: Lawson, D. (ed.): Proceedings of the 9th International Cystic Fibrosis Congress, Brighton, England, 1984. John Wiley & Sons, Chichester, 1984, p. 294.

    Google Scholar 

  33. Bender, S. W., Posselt, H.-G., Wönne, R., Stöver, B., Strehl, R., Shah, P. M.: Oral ciprofloxacin forPseudomonas bronchopneumonia in cystic fibrosis. Lawson, D. (ed.): Proceedings of the 9th International Cystic Fibrosis Congress, Brighton, England, 1984 John Wiley & Sons, Chichester, 1984, p. 293.

    Google Scholar 

  34. Roberts, C. M., Batten, J., Hodson, M. E.: Ciprofloxacin-resistantPseudomonas. Lancet 1985, i: 1442.

    Article  Google Scholar 

  35. Crook, S. M., Selkon, J. B., Smith, P. D. M.: Clinical resistance to long-term oral ciprofloxacin. Lancet1985, i: 1275.

    Article  Google Scholar 

  36. Miller, M. G., Ghoneim, A. T., Littlewood, J. M.: Use of enoxacin in a patient with cystic fibrosis. Lancet 1985, i: 646.

    Article  Google Scholar 

  37. Norden, C. W., Shinners, E.: Ciprofloxacin as therapy for experimental osteomyelitis caused byPseudomonas aeruginosa. Journal of Infectious Diseases 1985, 151: 291–294.

    PubMed  CAS  Google Scholar 

  38. Nord, C. E., Delin, C., Bergan, T., Johansen, S., Kolstad, I. M., Thorsteinsson, S. B.: The effect of ciprofloxacin on oropharyngeal and colon microflora. Research and Clinical Forums 1985, 7: 89–94.

    Google Scholar 

  39. Rozenberg-Arska, M., Dekker, A. W., Verhoef, J.: Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: The effect on fecal flora. Journal of Infectious Diseases 1985, 152: 104–107.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Microbiology, Statens Seruminstitut, Rigshospitalet, Afs. 7806, Tagensvej 20, DK-2200, Copenhagen N, Denmark

    N. Høiby

Authors
  1. N. Høiby
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Høiby, N. Clinical uses of nalidixic acid analogues: the fluoroquinolones. Eur. J, Clin. Microbiol. 5, 138–140 (1986). https://doi.org/10.1007/BF02013968

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013968

Search

Navigation